Funder: [National Institutes of Health (NIH) - https://www.nih.gov]
Due Dates: April 4, 2025 (New, Renewal, Resubmission) | Last possible due date: April 5, 2025 (Expired)
Funding Amounts: Up to $275,766 for Phase I (up to 2 years) and $1,838,436 for Phase II (2-3 years); NIH may exceed these amounts for specific topics.
Summary: Supports U.S. small businesses developing non-addictive pain therapies, devices, objective pain measurement tools, and screening models to improve pain management without clinical trials.
Key Information: Clinical trials are not allowed under this FOA; applications must focus on non-addictive pain management solutions within the NIH HEAL Initiative.